BlossomHill Therapeutics and Foundation Medicine, Inc. have partnered to develop a companion diagnostic assay for BH-30643. This assay will detect the EGFR C797S resistance mutation, a key challenge in treating non-small cell lung cancer. The collaboration aims to guide the

Diagnostics

Categories